Govt Places Second Purchase Order for 1 Crore Covishield Doses
Published On Feb 04, 2021, Updated On Feb 04, 2021
The Centre has placed its second purchase order with the Serum Institute of India for its covid-19 vaccine. The order is regarding the supply of 1 crore doses of Covishield, the Indian version of the Oxford-AstraZeneca coronavirus vaccine. According to the sources, the cost of each dose is Rs. 210, including GST.
The public sector undertaking, HLL Lifecare Limited issued the supply order in the name of Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), Pune. It must be noted that the order was placed on behalf of the Union health ministry.
Earlier, on January 11, the Indian government had placed an order for 1.1 crore Covishield doses at the cost of Rs. 231 crore, which has now increased to Rs. 441 crore with this second order. On January 11, the government had also committed to buy 4.5 crore doses of the novel coronavirus vaccine from the Serum Institute, in addition to the first order of 1.1 crore doses.
Serum Institute’s Covishield and Bharat Biotech’s Covaxin had received emergency use approval in early January this year.
You May Also Like To Read:
Disclaimer: This article is issued in general public interest and meant for general information purposes only. Readers are advised not to rely on the contents of the article as conclusive in nature and should research further or consult an expert in this regard.